Bee Sting Allergy
Find information on bee sting allergy (ICD-10 T78.40XA, T78.49XA), including diagnosis, treatment, and management of bee allergy and hymenoptera venom allergy reactions. Learn about clinical documentation best practices for bee sting allergy, coding for allergic reactions to bee stings, and healthcare guidelines for patients with bee venom allergies. Explore symptoms, anaphylaxis risk, and immunotherapy options for bee sting allergy.
Allergic reaction to bee venom, ranging from mild skin reactions to life-threatening anaphylaxis.
Swelling, hives, itching, redness, shortness of breath, dizziness, anaphylaxis.
Outdoors, gardens, parks, picnics. Emergency room, allergy clinic for testing and treatment.
ICD-10 Code Families
Complete code families applicable to T63.441A
When to use each related code
| Description | When to use |
|---|---|
| Allergic reaction to bee stings. | Use for reactions to bee stings, from mild to severe. Consider specific bee if known. |
| Allergic reaction to wasp, hornet, or yellow jacket stings. | Use for reactions to stings from wasps, hornets, or yellow jackets. Consider species if known. |
| Allergy to insect stings, not otherwise specified. | Use for insect sting allergies when the specific insect is unknown or not bee/wasp/hornet/yellow jacket. |
Best-practice checklist
- ✓Bee sting reaction specifics (local vs systemic)
- ✓Document severity: Mild, moderate, or severe symptoms
- ✓Onset and duration of reaction symptoms
- ✓Treatment provided and patient response details
- ✓ICD-10-CM code T78.4XXA confirmed
Common pitfalls to avoid
Coding bee sting allergy requires specific documentation of bee venom, not just general insect allergy. ICD-10 coding guidelines are crucial for proper diagnosis coding (e.g., T78.40XA vs. T78.409A).
Clinical validation of bee sting allergy is necessary. Symptoms alone are insufficient for ICD-10-CM diagnosis coding. Risk of inaccurate coding and healthcare fraud if unsubstantiated.
Properly code the specific manifestation (anaphylaxis, urticaria, etc.) associated with the bee sting allergy. Incorrect sequencing can impact reimbursement and quality reporting. Review official coding guidelines for correct coding.
Best-practice tips
- 01Carry epinephrine autoinjector (ICD-10 T63.401A, T78.40XA).
- 02Wear medical ID bracelet (SNOMED CT 420385009).
- 03Avoid strong scents, bright colors (ICD-10 Z91.01, Z71.89).
- 04Inspect outdoor areas for bees (E/M coding for allergy assessment).
- 05Seek allergy testing and desensitization (CPT 95004, 95165).
Step-by-step checklist
- 1
1. Confirm localized reaction vs systemic symptoms (ICD-10 T63.401A, W57.XXXA).
- 2
2. Document sting source: Honeybee, wasp, hornet, etc. (SNOMED CT 704145003).
- 3
3. Assess respiratory, cardiovascular, cutaneous manifestations.
- 4
4. Evaluate history of previous reactions, atopy, medications.
Ready-to-paste narrative
Patient presents with suspected bee sting allergy, also known as Hymenoptera venom allergy, following a recent bee sting incident. Symptoms reported include localized swelling, redness, and itching at the sting site, progressing to urticaria, angioedema, and dyspnea. Patient denies prior diagnosed bee allergy but reports a family history of allergic reactions. Physical examination reveals localized erythema and edema consistent with a type I hypersensitivity reaction. Differential diagnoses considered include other insect bite reactions, cellulitis, and drug reactions. Given the systemic symptoms and patient presentation, bee sting allergy is the most likely diagnosis. Diagnostic testing may include skin prick testing or serum-specific IgE testing to confirm bee venom allergy. Initial treatment consisted of intramuscular epinephrine injection and administration of oral diphenhydramine. Patient responded favorably to treatment with resolution of respiratory symptoms and decreased angioedema. Patient education provided on bee sting avoidance, epinephrine auto-injector use, and the importance of follow-up with an allergist for venom immunotherapy evaluation. ICD-10 code T78.01XA, adverse effect of venom of bees, initial encounter, is documented. This diagnosis warrants further evaluation and management to mitigate future anaphylactic reactions. Patient is advised to obtain and carry an epinephrine auto-injector at all times.
Common questions and answers
How can I differentiate between a local bee sting reaction and a systemic allergic reaction requiring epinephrine in a pediatric patient?+
Differentiating between a local and systemic bee sting reaction is crucial for appropriate management, especially in children. A local reaction typically presents with pain, swelling, redness, and itching confined to the sting site. While uncomfortable, these symptoms are usually self-limiting and can be managed with local wound care, ice, and oral antihistamines. A systemic allergic reaction, however, involves multiple organ systems and necessitates prompt intervention with epinephrine. Symptoms may include hives, widespread itching, swelling of the face, lips, or tongue (angioedema), difficulty breathing or swallowing, wheezing, abdominal cramping, vomiting, dizziness, and loss of consciousness. Any signs of a systemic reaction warrant immediate epinephrine administration and transfer to the emergency department. Consider implementing a standardized protocol for bee sting reaction assessment in your pediatric practice to ensure consistent and appropriate management. Explore how S10.AI can assist in developing and implementing such protocols.
What are the best practices for prescribing and administering epinephrine auto-injectors (EAIs) for patients with confirmed bee sting allergy, considering different age groups and weight ranges?+
Prescribing and administering EAIs requires careful consideration of the patient's age and weight. For children weighing 15-30 kg, a 0.15 mg dose is typically recommended, while those weighing over 30 kg should receive a 0.3 mg dose. Two EAIs should always be prescribed, and patients and caregivers must be educated on proper administration technique, including intramuscular injection into the anterolateral thigh. Practical demonstrations and regular reviews are essential. Additionally, patients should be advised to seek immediate medical attention after using an EAI, even if symptoms subside, for observation and potential further treatment. Learn more about S10.AI's resources for patient education materials and EAI training guides.
What are the diagnostic criteria for bee sting allergy, and how can I accurately assess a patient's risk for future systemic reactions following a sting? What role does venom immunotherapy play in long-term management?+
Diagnosing bee sting allergy involves a thorough clinical history, including details of the reaction, and skin testing or serum-specific IgE testing to confirm sensitization to bee venom. Skin testing is often preferred due to its higher sensitivity and faster results. A positive test indicates sensitization, but not necessarily clinical allergy. The patient's history, including the severity of the previous reaction, is key to risk stratification. Venom immunotherapy (VIT) is the only disease-modifying treatment for bee sting allergy and is indicated for patients with a history of systemic reaction. VIT involves administering gradually increasing doses of bee venom, leading to desensitization and reducing the risk of future systemic reactions. Explore how S10.AI can help you navigate the complexities of bee sting allergy diagnosis and personalize VIT recommendations based on patient-specific factors.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.